Nuclear Med Technol-PRN-PCM

Written by piedmont - - Comments Off on Nuclear Med Technol-PRN-PCM
Piedmont Healthcare
Published
June 3, 2021
Location
Columbus, Georgia
Job Type
PRN  

Description

Piedmont Healthcare Logo

Nuclear Med Technol-PRN-PCM-Columbus,GA

Job Number: 1057375

Piedmont Columbus Regional - Columbus, Georgia
Shift/Schedule: PRN

Description

Performs CT studies and diagnostic and therapeutic Nuclear Medicine and/or Nuclear Cardiology procedures according to all Protocols, Policies and Procedures and adhering to A.L.A.R.A. programs. Performs all quality control procedures in accordance with manufacturer, state and federal guidelines. Performs related record-keeping and patient care functions utilizing established protocols and techniques differentiating for infant, child, adolescent, adult and geriatric patient population in the performance of procedures and functions.

Requirements

MINIMUM EDUCATION REQUIRED:

Graduate of an AMA approved Radiologic Technology or Nuclear Medicine program.

MINIMUM EXPERIENCE REQUIRED:

A minimum of one (1) year experience as a Radiological Technologist or Nuclear Medicine Technologists.

MINIMUM LICENSURE/CERTIFICATION REQUIRED BY LAW:

Registered by the American Registry of Radiologic Technology in (CT) or as Registered nuclear technologist with either the American Registry of Radiologic Technologist (Nuclear) ARRT (N) or the Nuclear Medicine Technologist Certification Board (NMTCB-CNMT).

Diversity & Inclusion

At Piedmont Healthcare we embrace diverse ideas, perspectives, and skills to create a collaborative workplace where the best talent wants to succeed. We celebrate differences and recognize that they allow us to care for our community.

Excellence at Work

Piedmont is a certified Great Place to Work™-- a national designation based on employee feedback about trust, workplace culture and experience. In 2019, Forbes named Piedmont one of Georgia’s 10 best employers and the highest-ranked healthcare provider.

 

© 2021 Piedmont Healthcare

Related Jobs

Comments are closed.